TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06037499

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Glucometer Test
Description: measurement of blood glucose concentration using different BGM and Reference Method
Study: NCT05747417

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: prismatic glasses
Description: prism glasses ranging from 4-10 prism diopters
Study: NCT06496399

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: psychoeducation
Description: -The elderly's preferences for art therapy (art activities such as wood painting, creating shapes with mud) will be taken into account.~2-Expression of emotions through motivational interviewing 3-Conscious Awareness therapy, staying in the moment here and now 4- Hobbies (growing flowers, gardening, handicraft knitting, puzzle solving, card games, chess game, etc., organizing trips, cinema, movie events and so on)
Study: NCT05283876

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Excimer light
Description: Excimer light sessions

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Excimer light
Description: Excimer light sessions
Study: NCT05794295

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acoustic Stimulation (AS)
Description: Acoustic Stimulation will be administered while participants have their sleep monitored.

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: SHAM Stimulation
Description: No stimulation will be administered while participants have their sleep monitored.
Study: NCT05068050

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Horse-assisted therapy
Description: 12 horse-assisted therapy sessions (45 mins each) for 6 weeks.~Each session will comprise the next stages:~Groundwork, Approachment and preparation of the horse, Warm up exercises~Development of the main part (riding):~Introduction - beginning: Breathing control and body awareness, maintain sitting (riding position) while walking on the horse, perceiving the movement Exercises for the postural and balance control: Variations in the walking of the horse, realize different figures in the arena (circles, serpentines, change direction...), Stopping and Walking, Arms situation combined with the movement of the horse All exercises are determined in the track design protocol Exercises for the acquisition of motion skills: Finished the riding with relaxation activities. Final part: Dismount the horse, Unsaddled and unbridle, feedback and goodbye procedure.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Physical exercise
Description: 12 physical exercise sessions (45 mins each) for 6 weeks. Each session Each session Lessons will be held by physical activity professionals. The proposed exercises are focussed on improving the articular movements, aerobic resistance and the proprioception, always on the premises of No Pain.~Lessons will be divided in three parts :~1. Warmup - 2. Main part - 3. Return to calm~Lessons will be hold online
Study: NCT06093321

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: SYB PDO Thread
Description: Apply the test device (SYB PDO Thread) and the control device (MINT lift®) with 7±1 lines on each side of the nasolabial fold.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MINT lift®
Description: Apply the test device (SYB PDO Thread) and the control device (MINT lift®) with 7±1 lines on each side of the nasolabial fold.
Study: NCT05386979

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Opioid free anesthesia technology
Description: We have adopted a variety of methods to replace the use of opioids in the process of balanced anesthesia.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Opioid free anesthesia technology
Description: We have adopted a variety of methods to replace the use of opioids in the process of balanced anesthesia.
Study: NCT06278194

Intervention type: PROCEDURE
Group type: OTHER
Intervention: Gasserian Ganglion Radiofrequency Thermocoagulation
Description: Gasserian ganglion radiofrequency thermocoagulation is performed in the operating room under fluoroscopy. In sterile condition, the foramen ovale is shown by the pain management specialist under fluoroscopy guidance. After this condition, the entry of the needle is marked and anaesthetised with local anaesthetic. After the entry of the gasserian ganglion with the radiofrequency needle, 10 cm long, the location is checked with sensory and motor stimulation. If the placement is correct, 70 degrees 70 seconds of radiofrequency thermocoagulation is applied.
Study: NCT05329662

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Autologous adipose-derived mesenchymal stem cell administration for female with sexual functional deficiency
Description: * Patients in the two groups will receive two autologous AD-MSC administrations: the group A on day 0 and day 90 ± 7; the group B on day 180 ± 14 and day 270 ± 14.~* Dose: 1.0 x 106 cells/kg patient bodyweight.~* Route: intravenous infusion~ADSCs were collected after the third passage. On the day of transplantation, the ADSCs were harvested, washed twice with NaCl 0.9%, counted and resuspended in NaCl 0.9% in a total volume of 20 ml. Each participant received a dose of 1x10\^6 cells/kg body weight infused through the intravenous route within 30 minutes before being discharged after 24 hours

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Autologous adipose-derived mesenchymal stem cell administration for female with sexual functional deficiency
Description: * Patients in the two groups will receive two autologous AD-MSC administrations: the group A on day 0 and day 90 ± 7; the group B on day 180 ± 14 and day 270 ± 14.~* Dose: 1.0 x 106 cells/kg patient bodyweight.~* Route: intravenous infusion~ADSCs were collected after the third passage. On the day of transplantation, the ADSCs were harvested, washed twice with NaCl 0.9%, counted and resuspended in NaCl 0.9% in a total volume of 20 ml. Each participant received a dose of 1x10\^6 cells/kg body weight infused through the intravenous route within 30 minutes before being discharged after 24 hours
Study: NCT06399744

Intervention type: PROCEDURE
Group type: OTHER
Intervention: sclerotherapy
Description: injection of sclerosing agent (tetracycline or polidocanol) into ovarian cyst after aspiration of its contents

Intervention type: PROCEDURE
Group type: OTHER
Intervention: sclerotherapy
Description: injection of sclerosing agent (tetracycline or polidocanol) into ovarian cyst after aspiration of its contents
Study: NCT04557033

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mindfulness intervention
Description: My Moments® application (app) is a tool used to facilitate expressive art creation in a digital photography media
Study: NCT06399575

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Apnea Following Isocapnic Hypoxia
Description: Decreasing end-tidal partial pressure of oxygen to 50 mmHg for five minutes, targeting 80-85% peripheral oxygen saturation. The end-tidal partial pressure of carbon dioxide will remain +1 mmHg above baseline levels. After five minutes of hypoxia, participants will complete an apnea.
Study: NCT04871256

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Septorhinoplasty
Description: This intervention will be performed by the same surgeon, after signing of patient inform consent.
Study: NCT05607745

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: FMT and placebo
Description: Similar healthy diet counseling is given to all participants in both FMT and placebo group. FMT to placebo is given in 2:1.

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: FMT and placebo
Description: Similar healthy diet counseling is given to all participants in both FMT and placebo group. FMT to placebo is given in 2:1.
Study: NCT05810714

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Best Practice
Description: Receive usual care

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Fecal Immunochemical Test
Description: Receive FIT kit

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fecal Immunochemical Test
Description: Receive FIT kit

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Fecal Immunochemical Test
Description: Receive FIT kit

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Education
Description: Receive audio brochure

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Health Education
Description: Receive video brochure

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scheduled Notification
Description: Receive scheduled reminder

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scheduled Notification
Description: Receive scheduled reminder

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Survey Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey Administration
Description: Ancillary studies
Study: NCT05291559

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Enterade
Description: Enterade is a glucose-free, amino acid-based medical food containing specific amino acids (aspartic acid, valine, serine, threonine and tyrosine) in addition to electrolytes and a non-sugar sweetener.

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo is an identical product to Enterade except without added amino acids.
Study: NCT04821323

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Indomethacin
Description: Indomethacin capsules will be administered orally.

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Lactulose-mannitol
Description: Lactulose-mannitol solution will be administered orally.
Study: NCT05956223

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Virtual Reality measurement of essential tremor and dystonia
Description: 1. The virtual reality (VR) platform, which detects whole-of-body movements. The VR environment is a series of sensors in a room that detect whole body motion and a series of sensors worn by the participant. As well the participant dons VR goggles that allows them to see a virtual environment in which they can perform the TETRAS.~   Within the VR platform, an avatar (an electronic image that represents the participant) is produced in the VR environment, and this will be used to review the participant.~2. Sensors for the detection of wrist, head and voice tremor. The sensors are small devices worn on the wrists and head of the participant and are similar to those used in the VR system. A microphone is attached to the participants to detect voice tremor.
Study: NCT04561739

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Paclitaxel coated balloon
Description: The Paclitaxel coated balloon is a paclitaxel-eluting rapid exchange balloon catheter for PTCA. Paclitaxel is the pharmacologically active substance for anti-neointima, whereas iopromide, a well-tolerated nonionic x-ray contrast agent, acts as a release-supporting additive.~The active drug coating is located on the surface of the balloon, which contains 3 μg Paclitaxel per 1 mm2. The spray coating of the mixture of paclitaxel and iopromide of the Swide is via ultrasound, with the crystal size\<2um.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Sirolimus eluting stents
Description: The device has a backbone of L605 cobalt chromium. The stent has a open cell, in-phase, peak-to-valley design. The strut thickness is 86 μm and has a stent profile less than 1.12mm. The polymer coating of the stent is a styrene-butadiene block copolymer. The antiproliferative drug concentration is at 9 ug/mm, which 80% of the drug is released by 30 days.
Study: NCT06170359

Intervention type: PROCEDURE
Intervention: robotic surgery under general anaesthesia
Description: During robotic surgery, the standard 45-degree upright Trendelenburg position and for postoperative analgesia, 0.06 mg/kg morphine, 1 gram (g) paracetomol and 8 mg onasetron are administered iv to all patients 30 minutes before the end of the operation. At the end of surgery and after extubation, patients are taken from the recovery unit to the service. In the service, all patients are given paracetamol 1g every 8 hours and tenoxicam 20 mg every 24 hours for pain treatment. Tramadol 1 mg/kg iv is administered as rescue analgesic to patients with a VAS score \>4.

Intervention type: PROCEDURE
Intervention: robotic surgery under general anaesthesia
Description: During robotic surgery, the standard 45-degree upright Trendelenburg position and for postoperative analgesia, 0.06 mg/kg morphine, 1 gram (g) paracetomol and 8 mg onasetron are administered iv to all patients 30 minutes before the end of the operation. At the end of surgery and after extubation, patients are taken from the recovery unit to the service. In the service, all patients are given paracetamol 1g every 8 hours and tenoxicam 20 mg every 24 hours for pain treatment. Tramadol 1 mg/kg iv is administered as rescue analgesic to patients with a VAS score \>4.
Study: NCT06505356

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prostate biopsy
Description: Transrectal prostate biopsy

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Prostate biopsy
Description: Transrectal prostate biopsy
Study: NCT05100160

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gabapentin
Description: Given by PO

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Given by PO
Study: NCT06006429

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Numerical dental impression by intraoral scanner
Description: Intervention consists in an 3D intra oral representation of the oral cavity
Study: NCT04460287

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: DHA Wet Mixing method
Description: Children will drink milk contain 100 mg DHA wet mixing daily for 30 days

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: DHA Wet Mixing method
Description: Children will drink milk contain 100 mg DHA wet mixing daily for 30 days

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: DHA Wet Mixing method
Description: Children will drink milk contain 100 mg DHA wet mixing daily for 30 days

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: DHA Dry Blending Method
Description: Children will drink milk contain 100 mg DHA dry blending daily for 30 days

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: DHA Dry Blending Method
Description: Children will drink milk contain 100 mg DHA dry blending daily for 30 days

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: DHA Dry Blending Method
Description: Children will drink milk contain 100 mg DHA dry blending daily for 30 days

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fish Oil
Description: Children will have this intervention every day for 30 days

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Fish Oil
Description: Children will have this intervention every day for 30 days

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Fish Oil
Description: Children will have this intervention every day for 30 days
Study: NCT06164366

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: 0 degrees 3D printed upper complete dentures
Description: 3d printed dentures at a build angle of 0 degrees

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: 45 degrees 3D printed upper complete dentures
Description: 3d printed dentures at a build angle of 45 degrees
Study: NCT06251089

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CPC mouthwash
Description: 0.07% CPC mouthwash

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo of the CPC mouthwash
Study: NCT05594901

Intervention type: OTHER
Intervention: Application of a prognostic score
Description: The CRECOOLT score, for the prospective cohort, will be systematically calculated once week, or at the occurrence of complications, until 60 days after OLT. The therapeutic management of all patients, during both retrospective and prospective periods, will be established by the attending physicians according with routine practice and not dictated by study protocol.
Study: NCT05545124

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donafenib + Tislelizumab
Description: Donafenib 100mg, BID+Tislelizumab 200mg, D1; q3w
Study: NCT04731571

Intervention type: RADIATION
Intervention: CBCT-guided Adaptive Radiotherapy
Description: The aim is to deliver adaptive radiotherapy using a CBCT-based radiotherapy delivery system.
Study: NCT04812808

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bazedoxifene 20 mg
Description: Bazedoxifene will be administered during the duration of the study in the experimental arm together with chemotherapy.~Prophylactic rivaroxaban (Xarelto®) 10 mg per day orally will be added to avoid thromboembolic events.
Study: NCT04794764

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: McGrath Mac
Description: in a randomized order we evaluate the first pass success rate of the tracheal tube into the trachea.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Macintosh Laryngoscope
Description: in a randomized order we evaluate the first pass success rate of the tracheal tube into the trachea.
Study: NCT05106608

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Energy density photobiomodulation (7.5)
Description: A total of 22 points will be treated (extraoral and intraoral). 2 sessions per week, for 3 months (24 sessions in total). In addition, a mobile health application (LAXER) will be provided.

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Energy density photobiomodulation (3)
Description: A total of 22 points will be treated (extraoral and intraoral). 2 sessions per week, for 3 months (24 sessions in total). In addition, a mobile health application (LAXER) will be provided.

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Sham placebo
Description: In addition, a mobile health application (LAXER) will be provided.
Study: NCT05644197

Intervention type: OTHER
Group type: OTHER
Intervention: Multidisciplinary program
Description: Multidisciplinary program:~* APA interventions: 12 weeks Each week at home, cardio-respiratory endurance sessions for muscle strengthening and balance work from the Autohome interface (Neuradom) and one week supervised by an APA teacher.~* Nutrition interventions: A group nutrition workshop at the Hôpital Privé de Provence.~* Psychological intervention:~  5 sessions of 1h30 in group, the first session will take place at the Private Hospital of Provence and the others by videoconference.~An individual session the week following the last group session.~-Visit with the urologist, 5 weeks after the prostatectomy.
Study: NCT01289379

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: High Frequency Jet Ventilation

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: HFJV
Study: NCT04848532

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Weight loss treatment
Description: The intervention will consist of group-based, weekly or biweekly weight loss coaching (75 minutes per session), which will occur via Zoom videoconferencing software. This intervention is designed to facilitate a 5-10% weight loss and engagement in up to 250 min/week of moderate-to-vigorous physical activity, which is the standard recommendation in lifestyle modification programs for adolescents. Participants will also be asked to download and utilize the smartphone app, Fitbit, to track eating behavior. Weight loss coaches will be experts in lifestyle modification who have graduate degrees in psychology or a related field. Participants will be given guidance on how to reduce your calorie intake (using a balanced deficit diet) and gradually increase your physical activity. Participants will learn to set goals for diet, weight, and physical activity.
Study: NCT06510855

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DurAVR™ THV System
Description: DurAVR™ THV System - Transcatheter Aortic Valve Implantation (TAVI) Procedure

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DurAVR™ THV System
Description: DurAVR™ THV System - Transcatheter Aortic Valve Implantation (TAVI) Procedure
Study: NCT04919668

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Simulated grocery shopping exercise
Description: Participants will click a link and simulate an online grocery shopping experience by selecting items for 12 grocery categories.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Simulated grocery shopping exercise
Description: Participants will click a link and simulate an online grocery shopping experience by selecting items for 12 grocery categories.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Simulated grocery shopping exercise
Description: Participants will click a link and simulate an online grocery shopping experience by selecting items for 12 grocery categories.

Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Simulated grocery shopping exercise
Description: Participants will click a link and simulate an online grocery shopping experience by selecting items for 12 grocery categories.
Study: NCT05932303

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986278
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986278
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BMS-986278
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Itraconazole
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Description: Specified dose on specified days
Study: NCT05875909

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: corneal flap transplantation
Description: Patients with macular holes underwent a 25-gauge, 3-port pars plana vitrectomy . Fluid-air exchange was performed in patients with pathologic myopia suffering from macular holes with retinal detachment. We used a flute needle to drain the subretinal fluid. A corneal flap was obtained by small incision lenticule extraction (SMILE). Stripping pliers were applied to spread corneal flap over the macular hole. A drop of fresh autologous whole blood was dripped over the corneal flap to immobilise it. The vitreous cavity was filled with 14% perfluoropropane (C3F8) for macular holes with retinal detachment . The surgical incision was self-closed or sutured with a 6-0 polyglactin 910 suture . The patients were instructed to maintain a prone position for 2 weeks postoperatively.